Faculty from the UNC School of Medicine were highlighted in several national and local media outlets during the week of March 27 to April 2, according to a March 31 announcement. The coverage includes research findings, expert commentary, and contributions to public health discussions.
The media appearances showcase the expertise of UNC School of Medicine faculty on a variety of medical topics that are relevant to both the scientific community and the general public. These features demonstrate ongoing research efforts and provide insights into emerging health issues.
Among the stories covered, Greg Wang was featured for his work on new approaches to treating aggressive cancer. Dr. Rachael Urrutia discussed hormone replacement therapy research with WTVD, while Dr. Melissa Haendel spoke about updated codes offering hope for rare diseases in Triangle Business Journal. Dr. Edwin Kim addressed pollen concerns on Spectrum News, and Dr. Gaorav Gupta discussed increased risks associated with BRCA mutations.
Other notable mentions include Dr. Frank Putnam’s discussion on how childhood sexual abuse affects survivors (Radio Health Journal), Dr. Scott Commins’ comments about tick-borne illnesses spreading (The New York Times), and Dr. Justin Yopp’s guidance tool for families when a parent has cancer (WRAL, MSN.com). Additional features included advice from Dr. Adam Miller regarding clinical trials (HealthCentral) and stories by Dr. Diana Cejas about delayed cancer diagnoses among medical trainees (ELLE, Yahoo).
Dr. Joseph Muenzer appeared twice: once discussing potential treatments for rare pediatric diseases (NBC News) and again highlighting UNC’s role in FDA approval of a new drug for genetic disorders (Newswise). In another report, Dr. John Batsis provided information about a ‘triple-G’ drug aiding significant weight loss (New York Post).
These appearances underscore UNC School of Medicine’s engagement with pressing health issues as well as its contribution to advancing medical knowledge through research shared with broad audiences.
